TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of days filled for consumptions
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Time to Bed
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: CPAP adherence
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: anti tumour immunity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Hydrops resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total amount of analgesics
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Progression-free Survival Rate at 3 Months
Endpoint domain: Mortality/survival
Primary endpoint: Mean AUC of percent increase in serum creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Need for ureteral stent placement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Improvement of treatment quality
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Walking ability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time taken from treatment start till body temperature dropping to normal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken from disease onset till body temperature dropping to normal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Top body temperature at the 24th hour, 48th hour and the 72th hour from treatment starting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resistance mechanism identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mean 24-hour ambulatory blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Central Subfield Retinal Thickness (CSRT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Youth PTSD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Youth PTSD re-arrest
Endpoint domain: Adverse events/effects
Primary endpoint: Social anxiety and avoidance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Effectiveness of botulinum toxin in reducing drooling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of scube1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Anxiety and preoccupation with body image
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Lowering fasting triglyceride
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent Change in Serum Thromboxane B2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from baseline tumor size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: STEEP treadmill test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Viral Suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in caregiver quality of life at 1 month
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Validation of LC-MS/MS analytical method
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Experience and feelings related to fertility and family planning
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Baseline-corrected late asthmatic response (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Plasma HIV RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensory processing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Obsessive-compulsive symptoms severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IA, IB, IIA, IIB, III, or humoral rejection diagnosed by biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Permanent resumption of dialysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Total weight lost percent (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Excess weight lost percent (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total weight regained percent (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Excess of weight regain percent (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of Adjunctive Therapy
Endpoint domain: Resource use
Primary endpoint: Presence of Breakthrough Parasitemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Time to Parasitemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pathologic Local Tumor Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Distance Visual Acuity (VA) - High Illumination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Vision With Digital Device Use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of pneumococcal carriage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Coefficient of variation of endothelial cell area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in typing test measurements (speed and accuracy)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease specific burden of chronic GVHD
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline in QTc
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in self-reported sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: amount of intraoperative fentanyl
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with decreased pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life measured by EQ-5D-5L
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Skin complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in Pain assessment
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Sleep arousal
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Metabolome signature of thyroid Hormone Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in Eudaimonic well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Sleep Quality: Actigraph
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: CEC, EMP and EPC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Serious adverse events and new chronic medical conditions requiring ongoing medical management
Endpoint domain: Adverse events/effects
Primary endpoint: Effect Compartment Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hallux valgus angle postoperative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Technical Success Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in attention performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of nails with Clinically Complete Cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the amount of drug in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative refractive sphere and cylinder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUClast of YH25448
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of YH25448
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability Assessment for Dementia (DAD)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: NPI-Caregiver Distress Scale (NPI-D)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Feasibility of Intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of Intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Appropriateness of Intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline in Pain Visual Analogue Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-report Concussion History
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cytokine levels (picograms per mL) between baseline and 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in cytokine levels (picograms per mL) 3 months after 2nd triamcinolone acetonide injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to Maximum Concentration (T-max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of peripheral sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in retinal amyloid burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentages of Subjects Without Bactericidal Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Functional assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of depression and anxiety level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ratio of atrial fibrillation (AF) episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Symptomatic palpitations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Functional Independence Measure (FIM) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cognitive performance measured by Stroop tests
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cognitive performance measured by Wechsler Forward Digit Span
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cognitive performance measured by Wechsler Backward Digit Span
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cognitive performance measured by Cancellation Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Duration of ICU and hospital stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Destination at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and Duration of SE episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Partial clinical remission (PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete clinical remission (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SpO2 (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3D kinematic measurements lower limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital mortality during index visit
Endpoint domain: Mortality/survival
Primary endpoint: Hospital length-of-stay (LOS)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Proportion of men with identifiable ERA atherosclerotic disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in 24-hour Average Systolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: serum HMGB1 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First episode of Upper Gastrointestinal Bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Adverse events related to endoscopic variceal ligation
Endpoint domain: Adverse events/effects
Primary endpoint: Predictive value of asthma diagnosis questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from Gross Motor function Measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma levels of inflammatory markers (cytokines and CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Diversity and levels of fecal microbes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Behavioral responses (symptoms)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cardiovascular risk as measured by Troponin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in International Index of Erectile Function (5-item Version)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Participants With Systemic (Non-Ocular) Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement of sitting time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Endoscope position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonatal gestational age at delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: # of neonates who were Small for gestational age (SGA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Troponin I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Creatinine phosphokinase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: C-reactive protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Unanticipated device-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: All Cause Mortality at 30 Days Post-procedure
Endpoint domain: Mortality/survival
Primary endpoint: Time until exhaustion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ED revisits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: biomarkers of liver functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with any adverse experience
Endpoint domain: Adverse events/effects
Primary endpoint: Change of sitting systolic and diastolic blood pressure (SiSBP, SiDBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Concordance rate between HRME imaging and histologic diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bio-equivalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kinematic characteristics of gait at heel strike
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Kinematic characteristics of gait at mid-stance phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Kinematic characteristics of gait at maximum motion in swing phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Periaqueductal Gray (PAG) Resting State Functional Connectivity (rsFC) Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Executive Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Implant survival at 3 years
Endpoint domain: Mortality/survival
Primary endpoint: Hearing and listening skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: proportion of individuals with IgE mediated allergic reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Cognitive function assessment (MMSE)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Disability assessment (Modified Rankin Scale)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Bacterial accumulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of Nephrogenic Systemic Fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of Participants With Ongoing Clinical Pregnancy Per Embryo Transfer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Body Weight - Mean Percent Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Weight - Proportion of Subjects With ≥5% Decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital return rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Vitreous hyperreflective dots
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Burden of maternal and neonatal death and still births
Endpoint domain: Mortality/survival
Primary endpoint: Safety and tolerability of GMI-1271
Endpoint domain: Adverse events/effects
Primary endpoint: Cumulative Incidence of Grade II to IV aGvHD
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with perineal tears
Endpoint domain: Adverse events/effects
Primary endpoint: Communication Function Classification System (CFCS)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: The Pediatric Functional Independence Measure (WeeFIM)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The Gross Motor Function Measure-88 (GMFM-88)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Visibility score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-tz (area under the concentration-time curve of the analyte in plasma)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With rtPCR-confirmed Influenza-Like Illness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Symptom-related distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Control of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgery Occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Target lesion pigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: improvement in patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Second Look Rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Free flap survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Global function assessment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Seizures Per Month
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Standing Balance - Sway Path
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standing Balance - Critical Point in Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standing Balance - Critical Point in Distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom Relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With HIV Viral Suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Participants With Heroin Use (Urine Drug Screen)
Endpoint domain: Adverse events/effects
Primary endpoint: Participants With Heroin Use (Self-report)
Endpoint domain: Adverse events/effects
Primary endpoint: Annualized Slope of Change in Total Kidney Volume (TKV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Annualized Rate of Change in Estimated Glomerular Filtration Rate (eGFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: NY-ESO-1 Specific Humoral Immunity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: NY-ESO-1 Specific Cellular Immunity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Delayed-Type Hypersensitivity (DTH) Skin Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Safety as Measured by Dose Limiting Toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility and likability of the sit-stand workstation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status